For the 52 weeks ending May 2, 2026, sales of 7.5-oz
The trial showed a 38% reduction in worsening heart failure events and a 56% reduction in hospitalization risk compared to placebo
If you experience any suspected side effects from your medication, you can report them via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk
Weight Loss in Obese Adults In a 48-week phase 2 trial published in The New England Journal of Medicine , retatrutide demonstrated unprecedented weight loss efficacy in adults with obesity
Oral weight loss pills like Wegovy work through the same GLP-1 mechanism, so weight loss pills' side effects are similar to the injection, primarily mild nausea and constipation
These innovative medications address the biological factors that make weight loss difficult, providing a powerful tool when combined with appropriate lifestyle modifications